Table 4. Univariate and multivariate analysis of DFS in HCC patients.
Variable | Number | Univariateanalysis | Multivariatenalysis | |
---|---|---|---|---|
P value | HR (95% CI) | P value | ||
Histology: | ||||
Tumor HNF-1B expression | ||||
Low vs High | 134 vs 49 | 0.021* | 1.443(1.021,2.039) | 0.038* |
Tumor K19 expression | ||||
Low vs High | 89 vs 94 | 0.128 | NA | |
Tumor K7 expression | ||||
Low vs High | 84 vs 99 | 0.051 | NS | |
Tumor EpCAM expression | ||||
Low vs High | 95 vs 88 | 0.684 | NA | |
Tumor OV6 expression | ||||
Low vs High | 88 vs 95 | 0.793 | NA | |
Non-tumor HNF-1B expression | ||||
Low vs High | 134 vs 49 | 0.014* | NS | |
Clinical characteristics | ||||
Age(yr) | ||||
<50 vs ≥50 | 96 vs 87 | 0.738 | NA | |
Gender | ||||
Male vs Female | 162 vs 21 | 0.695 | NA | |
Tumor size | ||||
<5 cm vs ≥5 cm | 89 vs 94 | 0.033* | NS | |
Tumor number | ||||
Single vs Multiple | 159 vs 24 | 0.433 | NA | |
Cirrhosis | ||||
No vs Yes | 125 vs 58 | 0.110 | NA | |
TNM stage | ||||
I/II vs III | 166 vs 17 | 0.004* | 1.802(1.057,3.072) | 0.030* |
HbsAg | ||||
Negative vs Positive | 11 vs 172 | 0.105 | NA | |
Serum AFP | ||||
<400 vs ≥400 | 116 vs 67 | 0.246 | NA | |
Histological grade | ||||
Well/moderate vs poorly | 133 vs 50 | 0.514 | NA | |
Lymphovascular invasion | ||||
Negative vs Positive | 66 vs 117 | 0.020* | 1.460(1.057,2.017) | 0.022* |
NA, not adopted; NS, not significant; HR, hazard ratio; Factors with p < 0.1 in univariate analysis were adopted for further multivariate analysis. *P < 0.05 was considered statistically significant.